Nektar Therapeutics (NASDAQ:NKTR)

11.57
BATS BZX Real-Time Price
As of 2:22pm ET
 +0.04 / +0.35%
Today’s Change
9.51
Today|||52-Week Range
17.53
-25.35%
Year-to-Date

Today’s Trading

Previous close11.53
Today’s open11.51
Day’s range11.37 - 11.78
Volume580,712
Average volume (3 months)1,755,212
Market cap$1.5B
Dividend yield--
Data as of 2:08pm ET, 05/27/2015

Growth & Valuation

Earnings growth (last year)+70.00%
Earnings growth (this year)-26.19%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)+34.77%
P/E ratio57.6
Price/Sales9.80
Price/Book41.64

Competitors

 Today’s
change
Today’s
% change
ARIAARIAD Pharmaceutical...+0.07+0.78%
PRAHPRA Health Sciences ...+0.13+0.40%
KERXKeryx Biopharmaceuti...+0.04+0.39%
FGENFibroGen Inc+0.61+3.46%
Data as of 2:22pm ET, 05/27/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$200.7M
Annual profit (last year)-$53.9M
Net profit margin-26.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Financial Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers